M05.85 Other rheumatoid arthritis with rheumatoid factor of hip

Name of the Condition

• Other rheumatoid arthritis with rheumatoid factor of hip (ICD-10: M05.85)

Summary

This condition is a subtype of rheumatoid arthritis (RA) characterized by chronic inflammation of the hip joint, accompanied by the presence of rheumatoid factor (RF) in the blood. It involves immune system activity targeting the hip, leading to joint damage and associated symptoms.

Causes

RA is an autoimmune disorder where the immune system mistakenly attacks the body’s tissues. Genetic predisposition, environmental factors (e.g., smoking), and hormonal influences may contribute to its development. The presence of RF indicates an immune response associated with this form of arthritis.

Risk Factors

• Risk factors include a family history of RA, female gender, smoking, obesity, and exposure to certain environmental triggers. Age (commonly 40–60 years) and genetic markers may also increase susceptibility.

Symptoms

• Patients typically experience joint pain, swelling, stiffness (especially morning stiffness), fatigue, and reduced range of motion in the hip. Systemic symptoms like fever or weight loss may occur if inflammation is widespread.

Diagnosis

Diagnosis involves a combination of medical history, physical examination, blood tests for RF and other inflammatory markers, and imaging (e.g., X-rays, MRI) to assess joint damage. Clinical criteria for RA are applied, with attention to hip-specific involvement.

Treatment Options

• Treatment may include disease-modifying antirheumatic drugs (DMARDs), biologics, nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, and in severe cases, surgical intervention (e.g., hip replacement). Early treatment aims to reduce inflammation and preserve joint function.

Prognosis and Follow-Up

Prognosis varies based on disease severity, response to treatment, and presence of complications. Regular follow-up with a rheumatologist is essential to monitor disease activity, adjust therapy, and address joint damage progression. Early intervention improves long-term outcomes.

Complications

• Potential complications include joint deformity, loss of mobility, osteoporosis, cardiovascular disease, and increased infection risk due to immunosuppressive therapies. Hip involvement may lead to significant functional impairment if untreated.

Lifestyle & Prevention

• Maintaining a healthy weight, avoiding smoking, and engaging in low-impact exercise (e.g., swimming) may help reduce joint stress. Physical therapy can improve mobility and strength. While prevention is not possible, early detection and treatment mitigate progression.

When to Seek Professional Help

Seek care if experiencing persistent hip pain, swelling, or stiffness, especially with morning stiffness lasting over 30 minutes. Rapid worsening of symptoms or systemic signs (e.g., fever) requires prompt evaluation to prevent irreversible joint damage.

Tips for Medical Coders

Document the specific hip involvement and confirm the presence of rheumatoid factor. Ensure clinical documentation supports the diagnosis and site specificity. Code M05.85 is used when the hip is the documented site of other rheumatoid arthritis with rheumatoid factor.